From Hemoglobin to Beta-Cell Function: Practical Challenges, Standardization, and Clinical Use of HbA1c and C-Peptide Testing
Thursday, July 30
10:15 – 11:15 a.m.
Exhibit Hall Theater 1
Presented by Tosoh Bioscience Inc.
Overview
This workshop explores the evolving landscape of diabetes diagnostics, beginning with the importance of modern biomarkers. It provides a practical review of HbA1c testing, including method differences, standardization efforts, and the impact of hemoglobin variants. The session also examines the clinical role of C-peptide and current challenges in assay standardization. The program concludes with an integrated view of how these markers can be used together and a look at future directions in diabetes assessment.
Outcome
- Understand the strengths and limitations of HbA1c methods, including how hemoglobin variants can affect result reliability
- Describe the clinical utility of C-peptide and recognize key issues in assay standardization
- Apply an integrated perspective on HbA1c and C-peptide testing to support more informed decision-making in diabetes assessment and future diagnostic strategies
Moderator
Priya Sivaraman, Ph.D.
Senior Technical Product Manager, Tosoh Bioscience Inc.
Speaker
Kuanysh Kabytaev, Ph.D.
Director, DDL; Member, NGSP Steering Committee
Diabetes Diagnostics Laboratories (DDL), University of Missouri